SeaStar Medical Holding (ICU) Gains from Investment Securities (2021 - 2025)
SeaStar Medical Holding's (ICU) quarterly Gains from Investment Securities came in at -$16000.0 in Q3 2025, up 91.67% YoY from -$8347.8 in Q3 2024, and little changed on a QoQ basis from -$16000.0 in Q2 2025.
SeaStar Medical Holding (ICU) Gains from Investment Securities (2021 - 2025) Analysis & Trends
SeaStar Medical Holding (ICU) has 5 years of Gains from Investment Securities data on file, last reported at -$16000.0 in Q3 2025.
- Quarterly Gains from Investment Securities rose 91.67% year-over-year to -$16000.0 in Q3 2025, while the trailing twelve-month figure through Mar 2026 was -$32000.0 (up 98.52% YoY) and the FY2025 annual result came in at -$32000.0, down 104.59% from the prior year.
- Gains from Investment Securities was little changed at -$16000.0 in Q3 2025, from -$16000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $2.8 million in Q1 2024 to a low of -$10.9 million in Q4 2022.
- A 5-year average of -$843125.5 and a median of -$76000.0 in 2024 frame the typical range for Gains from Investment Securities.
- Annual changes were most pronounced in 2022 — Gains from Investment Securities plunged 1589.31% — and 2024, when it surged 8005.56%.
- Tracing ICU's Gains from Investment Securities over 5 years: stood at $729400.0 in 2021, then tumbled by 1589.31% to -$10.9 million in 2022, then surged by 111.41% to $1.2 million in 2023, then slumped by 106.13% to -$76000.0 in 2024, then surged by 78.95% to -$16000.0 in 2025.
- The last three Gains from Investment Securities figures came in at -$16000.0 (Q3 2025), -$16000.0 (Q2 2025), and -$16000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | SeaStar Medical Holding | 13.68 Mn | 6.68 Mn | 561,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -16,000.00 |
| Sep 30, 2025 | -16,000.00 |
| Jun 30, 2025 | -16,000.00 |
| Jun 30, 2025 | -16,000.00 |
| Mar 31, 2025 | -16,000.00 |
| Mar 31, 2025 | -16,000.00 |
| Dec 31, 2024 | -76,000.00 |
| Dec 31, 2024 | -76,000.00 |
| Sep 30, 2024 | -192,000.00 |
| Sep 30, 2024 | -192,000.00 |
| Jun 30, 2024 | -1.88 Mn |
| Jun 30, 2024 | -1.88 Mn |
| Mar 31, 2024 | 2.85 Mn |
| Mar 31, 2024 | 2.85 Mn |
| Dec 31, 2023 | 1.24 Mn |
| Dec 31, 2023 | 1.24 Mn |
| Sep 30, 2023 | -1.03 Mn |
| Sep 30, 2023 | -1.03 Mn |
| Jun 30, 2023 | -723,000.00 |
| Jun 30, 2023 | -723,000.00 |